FindTrial
Sign In

Heavy metal in cytopenias

A explorative study to asses the prevalence of heavy metal level abnormalities in patient presenting with unexplained cytopenia/low risk to a tertiary care hospital in North India - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067812
Enrollment
207
Registered
2024-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D538- Other specified nutritional anemias

Interventions

Control Intervention1: Nil: Nil

Sponsors

ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patient satisfying who criteria for cytopenia

Exclusion criteria

Exclusion criteria: Patient with abnormal cytogenetics,NGS, pregnant, greater than 5% blast in bone marrow, pregnant female, organ dysfunction

Design outcomes

Primary

MeasureTime frame
prevalence of heavy metal level abnormalities in patient with unexplained cytopenia’s and low blasts MDSTimepoint: BASELINE—

Secondary

MeasureTime frame
To assess the effect of supplementation/chelation in patients with cytopenia with heavy metal abnormalities.Timepoint: 3 months—

Countries

India

Contacts

Public ContactDr Kartikey Saini

All India Institute of Medical Sciences New Delhi

mukulmamc@gmail.com8800898282

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026